[Federal Register Volume 65, Number 48 (Friday, March 10, 2000)]
[Notices]
[Pages 13013-13014]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-5785]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Prospective Grant of Exclusive License: Use of Thymosin [4 for 
Wound Healing Applications; Correction

    The notice published in the February 28, 2000 Federal Register--
announcing the prospective grant of an exclusive license for use of 
thymosin 4 for wound healing applications (65 FR 10505)--
incorrectly listed one of the serial numbers for the subject invention 
as ``60/094,960'' under the SUMMARY section. NIH is publishing this 
notice to correct this serial number to read ``60/094,690.'' In view of 
this correction, to allow interested parties adequate time to respond, 
the DATES section is also amended to read ``Only written comments and/
or license applications

[[Page 13014]]

which are received by the National Institutes of Health on or before 
June 8, 2000 will be considered.''

    Dated: March 6, 2000.
Jack Spiegel,
Director, Division of Technology Development and Transfer, Office of 
Technology Transfer.
[FR Doc. 00-5785 Filed 3-9-00; 8:45 am]
BILLING CODE 4140-01-M